301408.SZ
华人健康
SZSE · F 批发零售 · CN
CNY 14.89
−3.87%Year over year
Reported trailing growth
- Revenue
- +20.2%
- EBITDA
- —
- EBIT
- +47.0%
- EPS
- +39.0%
- Free cash flow
- +3.2%
- Operating cash flow
- +0.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +18.9%
- EBITDA
- +10.4%
- EBIT
- +12.2%
- Net income
- +6.0%
- EPS
- +0.7%
- Free cash flow
- +114.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026